Eli Lilly & Co. (LLY)

116.80
0.29 0.25
NYSE : Health Technology
Prev Close 117.09
Open 116.99
Day Low/High 116.48 / 118.07
52 Wk Low/High 73.69 / 119.84
Volume 2.88M
Avg Volume 4.50M
Exchange NYSE
Shares Outstanding 1.06B
Market Cap 121.48B
EPS -0.20
P/E Ratio 244.00
Div & Yield 2.58 (1.94%)

Latest News

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Takeda Pharmaceutical CEO Talks Big Pharma Trends

One of pharma's biggest CEO's talks M&A action on the exchange.

Health Care Stocks Face Political Risk, How I'm Playing Netflix: Market Recon

Health Care Stocks Face Political Risk, How I'm Playing Netflix: Market Recon

Do we have to run for the hills? Not necessarily.

This Market May Just Be in an Uptrend: Market Recon

This Market May Just Be in an Uptrend: Market Recon

This is the kind of reversal that happens in a bull market.

Jim Cramer: Innovation Is on Display at the J.P. Morgan Healthcare Conference

Jim Cramer: Innovation Is on Display at the J.P. Morgan Healthcare Conference

We're out in San Francisco this week covering the amazing innovations that so many companies reveal at this annual conference.

Jim Cramer: These Pharma Deals Are Game Changers

Jim Cramer: These Pharma Deals Are Game Changers

Pharma companies that have cash are looking at what has happened to this stock market and buying.

Jim Cramer: They Might Be Done

Jim Cramer: They Might Be Done

Whether this is the end of the slump is still up for debate, but the crash since October has been brutal and all bear markets end the same way.

Eli Lilly's Technical Setup Looks So-So, So Be Ready to Take Action

Eli Lilly's Technical Setup Looks So-So, So Be Ready to Take Action

A close below $105 for the drugmaker's shares would be bearish based on its charts.

3 Tips for Trading the Fed's More Dovish Stance

3 Tips for Trading the Fed's More Dovish Stance

Anticipating a weaker dollar thanks to the shift in the Fed, which stocks are most likely to benefit?

Lilly Downgraded at Citi

Pfizer Shares Jump on Monday After Company Signals Higher Price Push

Pfizer Shares Jump on Monday After Company Signals Higher Price Push

Pfizer pushes higher on price increases.

Tech Selloff Could Work in Favor of Pharmaceutical Stocks

Tech Selloff Could Work in Favor of Pharmaceutical Stocks

Pharma could be the best parking spot for your money if the market keeps trending downward.

Pfizer, Other Pharma Stocks Should Continue to Do Well Amid Market Volatility

Pfizer, Other Pharma Stocks Should Continue to Do Well Amid Market Volatility

Pfizer trades with a trailing PE of 15 and is expected to grow earnings 2% in 2019.

Looking for Mr. Goodbar

"We're all hurt someplace and we're all looking for a painkiller." -- Katherine, Looking For Mr. Goodbar As I have previously remarked there is an old trading adage that long trading opportunities often occur in stocks that are green in a sea of red...

Eli Lilly Shares Decline on Tuesday Despite Strong Earnings Release

Eli Lilly Shares Decline on Tuesday Despite Strong Earnings Release

Eli Lilly's excellent earnings weren't excellent enough.

Eli Lilly's Conservative Pricing Offers Protection From Political Pressure

Eli Lilly's Conservative Pricing Offers Protection From Political Pressure

Eli Lilly's self-policing on drug pricing protects it from the most prominent political pushbacks.

Eli Lilly's Elanco Offload Offers Acquisition Flexibility

Eli Lilly's Elanco Offload Offers Acquisition Flexibility

Eli Lilly's confirmation of acquisition action could make pharmaceuticals an attractive investment space.

Wall Street Continues to See Opportunity in Eli Lilly

Wall Street Continues to See Opportunity in Eli Lilly

LLY's stock slide after earnings might present a buying opportunity.

2 Groups to Watch as the Midterm Election Unfolds: Cannabis and Drug Stocks

2 Groups to Watch as the Midterm Election Unfolds: Cannabis and Drug Stocks

A bunch of pot stocks are in play on Tuesday -- for a reason.

Eli Lilly Offers Healthy Outlook to Kick Off November

Eli Lilly Offers Healthy Outlook to Kick Off November

The giant drugmaker raised its profit guidance for all of 2018 after its third-quarter results beat expectations.

Eli Lilly Could Hit New Highs, but Market Weakness Could Mute Gains

Eli Lilly Could Hit New Highs, but Market Weakness Could Mute Gains

It shouldn't hurt that the drugmaker beat third-quarter estimates and raised its profit guidance for all of 2018.

Jim Cramer: Keep an Eye on the Insiders Who Are Buying

Jim Cramer: Keep an Eye on the Insiders Who Are Buying

Insiders buy for only one reason -- to make money.

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken

Once the safest stocks in the book, the big-cap drug companies are now toxic.

Eli Lilly Is Just Taking a Normal Pause

Eli Lilly Is Just Taking a Normal Pause

LLY has made a good run this year and now looks like it will correct a bit.

Jim Cramer: Avoid the Naked CEOs When the Tide Goes Out

Jim Cramer: Avoid the Naked CEOs When the Tide Goes Out

There is clear divergence between the best and the worst performers in each sector this earnings season.

Ford May Look Like a Value but It's Currently Dead Money

Ford May Look Like a Value but It's Currently Dead Money

There are concerns that interest rates may start to impact new car sales.

Constellation Brands Is a Bright Star on a Down Day

Constellation Brands Is a Bright Star on a Down Day

With STZ's earnings beat and the potential of the CGC investment, investors are willing to pay a premium.